News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Jantzen Beth
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/03/2021 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Granted 19,924 options to buy
@ $5.58, valued at
$111.2k
Granted 25,205 options to buy
@ $5.58, valued at
$140.6k
|
|
10/21/2020 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Granted 13,035 options to buy
@ $7.54, valued at
$98.3k
|
|
06/04/2020 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Granted 6,965 options to buy
@ $8.36, valued at
$58.2k
|
|
12/12/2018 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Disposed/sold 4,167 options to buy
@ $8.16, valued at
$34k
Granted 4,167 options to buy
@ $8.16, valued at
$34k
|
|
12/03/2018 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Disposed/sold 4,167 options to buy
@ $6.96, valued at
$29k
Granted 4,167 options to buy
@ $6.96, valued at
$29k
|
|
10/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/31/2018 |
4
| Jantzen Beth (CFO) has filed a Form 4 on APPLIED DNA SCIENCES INC
Txns:
| Granted 100,000 options to buy
@ $1.19, valued at
$119k
|
|
06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|